Detalhe da pesquisa
1.
Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.
Hepatology
; 69(6): 2338-2348, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30549279
2.
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.
Clin Infect Dis
; 55(5): 631-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22563020
3.
The dose-response relationship of peginterferon alfa-2a and ribavirin in the treatment of patients coinfected with HIV-HCV.
HIV Clin Trials
; 13(1): 33-45, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22306586
4.
Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.
HIV Clin Trials
; 13(2): 70-82, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22510354
5.
Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C.
Hepatology
; 52(6): 1906-14, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21064034
6.
Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial.
Clin Gastroenterol Hepatol
; 8(5): 458-62, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20156586
7.
Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up.
Hepatology
; 50(4): 1030-7, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19787818
8.
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
Hepatology
; 49(6): 1828-37, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19291787
9.
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Hepatology
; 49(6): 1847-58, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19434718
10.
A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.
Dig Dis Sci
; 55(9): 2629-35, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19960257
11.
One more piece in the interleukin 28B gene puzzle? The case of hepatitis B.
Hepatology
; 57(3): 870-2, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22911469
12.
Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection.
Hepatology
; 48(5): 1700-12, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18972443
13.
Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.
Clin Infect Dis
; 44(10): 1375-83, 2007 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17443478
14.
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
N Engl J Med
; 351(5): 451-9, 2004 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-15282352
15.
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Clin Gastroenterol Hepatol
; 5(2): 245-54, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17296533
16.
Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.
AIDS
; 20(3): 345-51, 2006 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-16439867
17.
Management of hepatitis C virus coinfection in HIV-infected persons.
AIDS Read
; 16(6): 313-6, 318-20, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16795921
18.
Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.
Infect Dis (Lond)
; 47(12): 924-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26365684
19.
Antiviral treatment of hepatitis C.
BMJ
; 348: g3308, 2014 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25002352
20.
IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy.
PLoS One
; 6(10): e25753, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22003405